跳至主要内容
临床试验/EUCTR2009-017649-67-IE
EUCTR2009-017649-67-IE进行中(未招募)不适用

Bone Health in Duchenne Muscular Dystrophy- a case controlled study of Risedronate use - Risedronate in DMD

The Central Remedial Clinic and The Children's University Hospital0 个研究点目标入组 70 人开始时间: 2010年1月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 1.>/4 years old at time of initiation of study
  • 2. Z score as measured by DXA >1.0 S.D. below the mean
  • 3. boys only with DMD
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Hypersensitivity to Risedronate sodium
  • 2. <4years at time of initiation of study
  • 3. Previous bisphosphonate use
  • 4. Uncorrected hypocalcaemia, uncorrected low Vitamin D
  • 5. Inability to stay in an upright position (sitting or standing) for at least 30minutes
  • 6. Severe renal impairment (creatinine clearance <30ml/min)
  • 7.Undergoing invasive dental treatment
  • 8. History of recent or active oesophageal or upper gastrointestinal problems
  • 9.History of oesophageal disorders which delay oesophageal transit or emptying e.g. stricture or achalasia
  • 10. Involvement in clinical trial in the preceding 12 weeks.
  • 11. Learning difficulties in carer resulting in difficulties comprehending treatment

研究者

发起方
The Central Remedial Clinic and The Children's University Hospital

相似试验